muscarinic M3 receptor antagonists (Nikem)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namemuscarinic M3 receptor antagonists (Nikem)
Drug Alias NameM3R antagonists (Nikem)diarylimidazolin-2-one derivatives (Nikem)NiK-19981
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsInflammationUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNikem Research Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNikem Research Srl
Active IndicationsN/A
Inactive IndicationsInflammationUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksN/A